Microdosing Tirzepatide for Weight Maintenance: Who It's For

You have reached your goal weight. The active weight loss phase is done, and now you are thinking about what comes next. If you have been on tirzepatide, you have probably wondered: can you stay on it at a lower dose, or do you need to stop completely?

The answer is more nuanced than yes or no. Tirzepatide microdosing, or staying on a significantly lower maintenance dose, is a clinical strategy that some providers use for patients who want to maintain their results. Doses below the labeled maintenance range are off-label, and there is no standardized protocol. But it is a real option worth discussing with a provider if you are interested in continuing medication at a lower dose (and, with some products, a lower cost).

What “tirzepatide microdosing” actually means

Tirzepatide microdosing does not have a formal definition in medical literature. When providers and patients talk about it, they mean staying on tirzepatide at doses lower than the ones used for active weight loss.

On the Zepbound label, treatment starts at 2.5mg once weekly for 4 weeks, then rises in 2.5mg steps, at least 4 weeks apart, up to a maximum of 15mg. The 2.5mg dose is for getting started only. For weight management, the labeled maintenance doses are 5mg, 10mg, or 15mg weekly, and the label tells prescribers to consider response and tolerability when choosing one, and to consider a lower maintenance dose if a higher one is not tolerated.^[2] Some programs go further and use ongoing doses below 5mg, such as 2.5mg or less. Those doses are off-label, which means a provider is using clinical judgment outside what the FDA reviewed.

The key point: the provider you choose makes this dosing decision based on clinical judgment, not from a textbook protocol. It is personalized to your situation.

Many lower-dose offerings use compounded tirzepatide. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.^[4] Compounded tirzepatide is not the same as brand-name products such as Zepbound or Mounjaro, and it may differ in formulation, purity, and potency.

Why lower doses might work for maintenance

Tirzepatide is a dual GLP-1 and GIP receptor agonist.^[2] This dual mechanism is part of what makes it effective for weight loss at higher doses. The idea behind lower-dose maintenance is that both receptors are still being activated at lower doses, just less strongly.

Think of appetite signaling like a volume knob. At the top of the dose range, the appetite signal is turned way down, which supports active weight loss. At a lower dose, the hope is that the signal is turned down enough to reduce the constant urge to eat, but not so aggressively that you feel completely suppressed.

For someone who has already lost weight and built new eating habits, that lower-volume appetite reduction may be enough to maintain stability with fewer side effects, and sometimes at a lower cost, than a full weight-loss dose. That is a reasonable hypothesis, not a tested result: no major trial has compared stepping down to a lower dose with staying on a full dose.

What the SURMOUNT-4 trial showed

The strongest evidence for why some people consider ongoing treatment comes from the SURMOUNT trial data. In the SURMOUNT-4 trial, published in JAMA in 2024^[1], adults took tirzepatide at their maximum tolerated dose (10mg or 15mg) for 36 weeks and lost an average of 20.9% of their body weight. They were then split into two groups: one switched to placebo, and one stayed on the same tirzepatide dose.

The findings were striking: over the next 52 weeks, the weight of those switched to placebo rose by an average of 14.0%, while those who continued tirzepatide lost a further 5.5% on average.^[1] Results vary, and trial results describe study participants, not what will happen for you.

One detail matters for microdosing. The people who kept their results in SURMOUNT-4 stayed on 10mg or 15mg. The trial did not test stepping down to a lower dose, so it supports continuing treatment, not any particular lower dose.

This tells you something important about what tirzepatide does. It is not just jumpstarting weight loss; it is actively managing appetite signals. When you stop the medication, that appetite regulation goes away, and for many people, the urge to eat returns. The regain is not a sign of failure. It is a sign that the medication was doing a real job managing a biological process.

Why maintenance is different from stopping entirely

If you stop tirzepatide completely, you are left with your baseline appetite signals. For many people who started on GLP-1 or tirzepatide in the first place, those baseline signals are difficult to manage. The SURMOUNT-4 data shows that directly: significant weight regain within a year is common.

With a maintenance dose, you are not eliminating appetite regulation; you are keeping it at a lower level. It is less aggressive than the active weight-loss dose, but it is still present.

The mechanism does not change when you go from 15mg to 5mg. The GLP-1 and GIP receptors are still being activated, which is how the medication reduces appetite and slows gastric emptying. You are just using a lower dose for a less aggressive effect.

What microdosing looks like in practice

If your provider recommends a maintenance dose, here is what that might look like:

You were on 15mg per week for active weight loss. Your provider discusses stepping down to 5mg per week, the lowest labeled maintenance dose. You do this gradually, monitoring how you feel and how your weight behaves.

At 5mg per week, you might find that your appetite is reduced but not suppressed. You feel normal hunger at meals, but you do not feel compelled to snack or think about food constantly throughout the day. Your weight stays stable.

The dose is adjusted based on your individual response. If 5mg is more than you need, some providers go lower, to 2.5mg or less, which is off-label. If 5mg is not enough and you are starting to experience hunger creep, your provider might suggest stepping up to 7.5mg.

This is clinical judgment, not protocol. Your provider is making decisions based on your specific situation: your response to medication, your eating habits, your goals, and your health history.

What to check before using tirzepatide

Lower-dose maintenance is offered by many telehealth programs and in-person practices, and the details vary a lot. Before you start, check:

• Your history. A licensed provider should review your prior GLP-1 use, your current weight, and any contraindications to continued tirzepatide use before prescribing a maintenance dose.
• Brand-name or compounded. Would your prescription be brand-name Zepbound or a compounded product (compounded products are not FDA-approved)? If compounded, which state-licensed pharmacy fills it, and is it a 503A or 503B pharmacy?
• The dose and whether it is on-label. Is the proposed dose one of the labeled maintenance doses (5mg, 10mg, or 15mg), or an off-label lower dose?
• The total cost. Prices vary by program and dose. Compare the total cost: medication, dose changes, visits, labs, shipping, membership fees, and cancellation terms.
• Monitoring. Who checks in on you, how often, whether lab work is involved, and whether follow-ups cost extra.

Transformation Health does not accept payment from providers. How we make money.

How the process should work

At most telehealth programs, getting a maintenance prescription follows similar steps:

1. You complete the program’s health questionnaire about your health history, your prior experience with GLP-1 medications, your current weight, and your goals.
2. A licensed provider (a physician, nurse practitioner, or physician assistant licensed in your state) reviews it and decides whether a maintenance dose is medically appropriate for your situation.
3. Many programs include a consultation by message, phone, or video. Some states require a live video visit before a first prescription, so ask whether yours does.
4. If a prescription is appropriate, it is filled by a pharmacy: a brand-name product through a retail or mail-order pharmacy, or a compounded product through a state-licensed compounding pharmacy.
5. You start on your prescribed maintenance dose, and the provider follows up to monitor your progress and adjust your dose if needed. Ask how often follow-ups happen before you sign up.

What happens if maintenance is not right for you

Microdosing is not the only path after reaching goal weight. Some people do better stopping medication entirely and maintaining through diet and exercise alone. Some people find that even a lower dose is more than they need. Some people stay on their active-weight-loss dose if they continue to have strong appetite signals.

A provider can discuss what makes sense for your specific situation. Lower-dose maintenance is one option among several. The goal is to find what works for you long-term, not to push you into any particular approach.

Key takeaways

• Tirzepatide microdosing has no official protocol. The labeled maintenance doses are 5mg, 10mg, or 15mg weekly; 2.5mg is a starting dose only, and ongoing doses below 5mg are off-label.
• The provider you choose determines the right maintenance dose for your situation based on your response, goals, and health history.
• In SURMOUNT-4, people switched to placebo saw their weight rise by an average of 14.0% over a year, while those who stayed on tirzepatide (10mg or 15mg) kept losing on average. The trial did not test lower doses. Results vary.
• Compounded tirzepatide is not FDA-approved and is not the same as brand-name tirzepatide.
• Before starting, compare the total cost, the product (brand-name or compounded), whether the dose is on-label, and how follow-up works.

What to read next

Learn more about the full path after reaching goal weight by reading GLP-1 Microdosing and Maintenance. If you are thinking about stopping medication entirely, Stopping Weight Loss Medication: What Happens walks through the trial data and what to expect.

For more details on how compounded tirzepatide works and how it differs from brand-name products, see Compounded Tirzepatide: What It Is and How It Works.

Transformation Health is relaunching as an independent GLP-1 guide with a free custom report that compares programs. Leave your email to be told when the report is available.

Citations

[1] Aronne LJ, et al. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.” JAMA. 2024;331(1):38-48. https://pubmed.ncbi.nlm.nih.gov/38078870/

[2] Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information, sections 1, 2.1, and 2.2 (revised 2026). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf

[3] Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information, section 1 (revised 2026). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866Orig1s052lbl.pdf

[4] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Accessed 2026-10-16. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss